Sex
Visit (Number) vs Age at Enrollment
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| Clinical Evaluation (CE) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| Diagnostic Visit (DX) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| CPAP Titration Visit (CPAP) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 3,032 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 3,032 |
Gender vs Age at Enrollment
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Gender vs Age at Enrollment
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Male | 958 | 49.7 | ± 13.0 | 50.0 | 18.0 | 84.0 | - | 958 |
| Female | 558 | 50.8 | ± 12.6 | 51.0 | 20.0 | 83.0 | - | 558 |
Race/Ethnicity vs Age at Enrollment
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |
Race/Ethnicity vs Age at Enrollment
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 50.1 | ± 12.9 | 50.0 | 18.0 | 84.0 | - | 1,516 |
| Native American | 28 | 48.7 | ± 10.0 | 48.0 | 29.0 | 65.0 | - | 28 |
| Asian | 89 | 41.0 | ± 11.8 | 41.0 | 18.0 | 72.0 | - | 89 |
| Black | 172 | 45.9 | ± 10.8 | 46.5 | 20.0 | 80.0 | - | 172 |
| Hispanic | 116 | 43.7 | ± 12.0 | 43.0 | 20.0 | 77.0 | - | 116 |
| White | 1,102 | 52.2 | ± 12.7 | 53.0 | 19.0 | 84.0 | - | 1,102 |
| Other | 9 | 48.3 | ± 9.9 | 48.0 | 36.0 | 64.0 | - | 9 |